Form 8-K - Current report:
SEC Accession No. 0001829126-25-005054
Filing Date
2025-07-14
Accepted
2025-07-14 16:45:28
Documents
15
Period of Report
2025-07-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K blackhawkacq_8k.htm   iXBRL 8-K 50224
2 EXHIBIT 3.1 blackhawkacq_ex3-1.htm EX-3.1 10130
3 EXHIBIT 10.1 blackhawkacq_ex10-1.htm EX-10.1 18606
  Complete submission text file 0001829126-25-005054.txt   309303

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE bkhau-20250708.xsd EX-101.SCH 4063
5 XBRL DEFINITION FILE bkhau-20250708_def.xml EX-101.DEF 27156
6 XBRL LABEL FILE bkhau-20250708_lab.xml EX-101.LAB 37607
7 XBRL PRESENTATION FILE bkhau-20250708_pre.xml EX-101.PRE 25776
17 EXTRACTED XBRL INSTANCE DOCUMENT blackhawkacq_8k_htm.xml XML 7304
Mailing Address 4125 BLACKHAWK PLAZA CIRCLE SUITE 166 DANVILLE CA 94506
Business Address 4125 BLACKHAWK PLAZA CIRCLE SUITE 166 DANVILLE CA 94506 203-520-7122
Black Hawk Acquisition Corp (Filer) CIK: 0002000775 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1130
Type: 8-K | Act: 34 | File No.: 001-41984 | Film No.: 251122184
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)